Biological kits/reagents 20028214 trusight oncology 500 DNA kit, for use with nextseq (48 samples) trusight oncology 500 DNA kit, for use with nextseq (includes DNA library prep and enrichment…
Ended Awarded Last action
- Contract number
- 75N91025F00023
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $248,921
Award facts
- Contract value 100% obligated
- $248,920.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the National Cancer Institute to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the procurement of Trusight Oncology 500 DNA kits for use with the NextSeq sequencing system. The award has a ceiling value of $248,920.63 and a period of performance through August 19, 2025. This delivery order is not associated with a set-aside program. Illumina, headquartered in San Diego, California, has been a prime contractor for numerous federal agencies, including the NIH, CDC, USDA, VA, and FDA, providing a range of advanced genomic sequencing platforms, reagents, and support services to enable critical research initiatives in areas such as infectious disease, cancer diagnostics, environmental monitoring, and agricultural genetic analysis.
Description
Biological kits/reagents 20028214 trusight oncology 500 DNA kit, for use with nextseq (48 samples) trusight oncology 500 DNA kit, for use with nextseq (includes DNA library prep and enrichment reagents and nextseq system core reagents) reagents r
Quick answers
Who was awarded contract 75N91025F00023?
75N91025F00023 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on June 19, 2025.
How much is contract 75N91025F00023 worth?
The government has obligated $248,921 on 75N91025F00023.
Is contract 75N91025F00023 an order under another contract?
Yes. 75N91025F00023 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N91025F00023 competed?
The extent of competition for 75N91025F00023 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award